SPONSORED CONTENT
The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims processing. While this may be true in certain circumstances, organizations providing or considering offering specialty medications can still successfully navigate these complexities with
…
SPONSORED CONTENT
The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of
…
*Sign up for news summaries and alerts from 340B Report
